YILIAM CLAVELO: Open Payments
NPI 1851541999 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,085 in 92 payments from 24 companies in 2025. Trend: 2023 $2,596 · 2024 $2,448 · 2025 $2,085
Food & beverage: $2,085
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $382 |
| GE HEALTHCARE | 7 | $204 |
| Neurocrine BioSciences, Inc. | 7 | $175 |
| PFIZER INC. | 9 | $161 |
| Eisai Inc. | 6 | $137 |
| UCB, Inc. | 4 | $131 |
| Amgen Inc. | 3 | $91 |
| Alnylam Pharmaceuticals Inc. | 3 | $88 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Alexion Pharmaceuticals, Inc. | 2 | $68 |
Products named: INGREZZA, VYALEV, NURTEC ODT, Leqembi, QULIPTA, ONPATTRO, Symbravo, Fintepla.
Industry payments across FL — which companies pay providers there.
